Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Teva Pharmaceutical Industries Ltd (TEVA)

17.92 0.08 (0.45%)

04-18 16:02

Open:

17.97

Pre. Close:

17.84

High:

18.01

Low:

17.805

Volume:

4,709,870

Market Cap:

18222M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.027 - 18.114

18.114 - 18.19

Low:

17.599 - 17.701

17.701 - 17.789

Close:

17.768 - 17.925

17.925 - 18.061

Technical analysis  (as of: 2018-04-18 4:44:51 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 22.66     One year: 26.47

Support:

Support1: 17.52    Support2: 16.35

Resistance:

Resistance1: 19.40    Resistance2: 22.66

Pivot:

17.48

Moving Averages:

MA(5): 18.01     MA(20): 17.38

MA(100): 18.48     MA(250): 21.28

MACD:

MACD(12,26): -0.12     Signal(12,26,9): -0.30

%K %D:

%K(14,3): 76.81     %D(3): 80.03

RSI:

RSI(14): 50.54

52-Week:

High: 33.82  Low: 10.85  Change(%): -41.7

Average Vol(K):

3-Month: 1286462  10-Days 801335

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TEVA has closed below upper band by 27.8%. Bollinger Bands are 40% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-19T00:38:33-04:00
Procter & Gamble pays Euro3.4B for Merck KGaA consumer health unit

2018-04-17T15:35:03-04:00
DEA aiming to collar production of opioids

2018-04-17T12:03:04-04:00
Sen. Sanders introduces bill to fine opioid makers for marketing practices

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

2018-04-17T08:00:00-04:00
Teva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the American Academy of Neurology

2018-04-16T11:23:01-04:00
Allergan Seeks Dumb Money For Its Women's Health Unit

2018-04-16T11:07:30-04:00
Top Trade Review

2018-04-16T06:59:02-04:00
Wall Street Breakfast: Russia, Ruble, Sanctions

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

1016.88

Shares Float (M)

1014.47

% Held by Insiders

0.20

% Held by Institutions

61.60

Shares Short (K)

59397

Shares Short Prior Month (K)

67930

Stock Financials

EPS

3.880

EPS Est. Current Year

4.230

EPS Est. Next Year

3.690

EPS Est. Next Quarter

1.090

Forward EPS

2.781

Book Value (p.s.)

1.350

PEG Ratio

-1.28

Profit Margin

Operating Margin

17.77

Return on Assets (ttm)

-20.2

Return on Equity (ttm)

-76.1

Qtrly Rev. Growth

-15.9

Gross Profit (p.s.)

10.645

Sales Per Share

EBITDA (p.s.)

-15.137

Qtrly Earnings Growth

Operating Cash Flow (M)

3510.00

Levered Free Cash Flow (M)

3530.00

atoplab.com

Valuation

P/E

4.62

P/E Growth Ratio

P/BV

13.27

P/S

829704960.00

P/CF

5.19

Dividend Yield

0.10

Dividends & Splits

Dividend

1.870

Dividend Pay Date

2017-12-12

Ex-Dividend Date

2017-11-27

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.